ときヲ(@toki_wo_koe) 's Twitter Profile Photo

ACEiとARBがICUせん妄を減らすか?
この研究では効果を示さなかったが面白い検討。

そもそも脳の網様体活性化系内のミグログリアの活性化と酸化ストレスを調節し、軽度〜中等度アルツハイマー病患者の記憶機能低下を遅らせる可能性があるらしい。⁦⁦Medscape Pharmacists⁩ medscape.com/s/viewarticle/…

account_circle
Vini - Sem Anistia(@Dramacoo1) 's Twitter Profile Photo

A tranquilidade de um remédio pra Alzheimer a custos de 26,5 MIL dólares anuais, perto de 140 mil reais. Lembrando q é uma doença crônica progressiva.
Toda vez esses preços me deixam bolado

account_circle
Freddy Pizart(@fpizart) 's Twitter Profile Photo

Medscape: RT Medscape Pharmacists: AbbVie raised its 2025 sales forecast of its newer immunology drugs Skyrizi and Rinvoq to more than $17.5 billion ms.spr.ly/6011etNg7 x.com/medscape/statu…

Medscape: RT @MedscapePharm: AbbVie raised its 2025 sales forecast of its newer immunology drugs Skyrizi and Rinvoq to more than $17.5 billion ms.spr.ly/6011etNg7  x.com/medscape/statu…
account_circle
PHARMACIST(@FrankkoskeiDr) 's Twitter Profile Photo

Sacubitril &valsartan belong to the new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI).
Used a a first line Rx of Chronic Heart Failure with reduced ejection fraction (HFrEF) with NYHA class II, III or IV.Dr.Dhruv Chauhan Medscape Pharmacists Aproko Pharmacist™

Sacubitril &valsartan belong to the new class of drugs called angiotensin receptor neprilysin inhibitor (ARNI). 
Used a a first line Rx of  Chronic Heart Failure with reduced ejection fraction (HFrEF) with NYHA class II, III or IV.@DrDhruvchauhan @MedscapePharm  @AprokoPhamacist
account_circle
Dr. AIE(@health_aie) 's Twitter Profile Photo

Aspirin 75mg though very affordable to many patients, it still pose a risk of GI bleeding which will necessitate addition of another medication to manage that resulting in poly pharmacy.
Best option is clopidogrel and ticagrelor

account_circle
Medscape Pharmacists(@MedscapePharm) 's Twitter Profile Photo

1 HR TO GO! Join this lively and interactive discussion about the use of oral selective estrogen receptor degraders (SERDs) in ER-positive/HER2-negative metastatic breast cancer.

❓ Leave your questions for our panel below.

1 HR TO GO!  Join this lively and interactive discussion about the use of oral selective estrogen receptor degraders (SERDs) in ER-positive/HER2-negative metastatic breast cancer. 

❓ Leave your questions for our panel below.
account_circle